LivingGLP1
GLP1_NEW

Liraglutide and metformin 1.2 to 0.85 mg injection once daily

LIRAMETF_SC_1p2-0p85MG_QD

Effects across outcomes

Bayesian random effects estimate against the comparator of each analysis (usually placebo), posterior median and 95% credible interval. Green: clearly better; red: clearly worse.
ConditionOutcomeWindowVersusEffect (95% CrI)SUCRA
Polycystic ovary syndromeNausealongest follow-upPlaceboHR 1.01 (0.14 to 6.70)0.63
Polycystic ovary syndromeDiarrhealongest follow-upPlaceboHR 1.79 (0.15 to 17.44)0.48

Trials